# ClinicalTrials.gov record NCT00439244

> PeptideScanner retained ClinicalTrials.gov record NCT00439244 at 2026-07-30T22:15:58.884Z. Its registry update date was 2011-04-20, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct00439244-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2011-04-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00439244-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00439244-teriparatide-v1.json
- Content SHA-256: `0bc6b87c9aa6e521de287e1b5a2e1addd8c0fa3466df0958d83a1eccdd321880`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00439244 ([`ctg-observation-nct00439244-2011-04-20-371f6bf34802`](#source-ctg-observation-nct00439244-2011-04-20-371f6bf34802))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00439244 at 2026-07-30T22:15:58.884Z. Its registry update date was 2011-04-20, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00439244-2011-04-20-371f6bf34802`](#source-ctg-observation-nct00439244-2011-04-20-371f6bf34802))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00439244 at 2026-07-30T22:15:58.884Z. Its registry update date was 2011-04-20, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00439244-2011-04-20-371f6bf34802`](#source-ctg-observation-nct00439244-2011-04-20-371f6bf34802))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00439244-2011-04-20-371f6bf34802`](#source-ctg-observation-nct00439244-2011-04-20-371f6bf34802))

## Sources

<a id="source-ctg-observation-nct00439244-2011-04-20-371f6bf34802"></a>
- **ClinicalTrials.gov record NCT00439244 · retained source version 2011-04-20:371f6bf348024ea9dd77f96a76421a0f1d4d406e2c94c62669acfaa4e696c5d7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00439244) (`ctg-observation-nct00439244-2011-04-20-371f6bf34802`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00439244." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00439244-teriparatide-v1.json SHA-256: 0bc6b87c9aa6e521de287e1b5a2e1addd8c0fa3466df0958d83a1eccdd321880.